type here...

CATEGORIES

Pharmaceutics

LATEST

123...11Page 1 of 11

TRENDING

EDITORS CHOICE

Mixing Covid Vaccines May Not Be a Great Idea, Research Shows

Medika Life -
Research from, Oxford's Com-Cov study highlights how mixing vaccine brands during follow-up covid vaccinations increases the risk of mild to moderate side effects.

Purdue Reformulated OxyContin to Reduce Abuse — Did They Succeed?

Jennifer Mittler-Lee B.S. Pharma -
OxyContin was neither superior to old-fashioned immediate-release oxycodone, a cheaper generic, nor did it offer any advantage over other opioids like morphine.

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

BIO – Biotech Without Borders 

Gil Bashe, Medika Life Editor -
This year’s gathering in Boston—a city long synonymous with health innovation—welcomed more than 20,000 attendees from across the globe. But what stood out most...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories